skip to content

Cambridge Public Health

 

Research Summary: Cancer risk prediction models

Publications from Elements

Journal articles

2020

  • Babb de Villiers, C., Kroese, M. and Moorthie, S., 2020. Understanding polygenic models, their development and the potential application of polygenic scores in healthcare. J Med Genet, v. 57
    Doi: http://doi.org/10.1136/jmedgenet-2019-106763
  • 2018 (Accepted for publication)

  • Mak, D., Babb de Villiers, CL., Chasela, C., Urban, MI. and Kramvis, A., 2018 (Accepted for publication). Analysis of risk factors associated with hepatocellular carcinoma in black South Africans: 2000-2012. PLoS ONE,
  • Antoniou, A., Lee, A., Mavaddat, N., Easton, D. and Cunningham, A., 2018 (Accepted for publication). BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and non-genetic risk factors Genetics in Medicine,
  • 2017 (Accepted for publication)

  • Antoniou, A., Carver, T., Lee, A., Cunningham, A., Babb de Villiers, C., Easton, DFE., Hartley, S., Tischkowitz, M. and Walter, F., 2017 (Accepted for publication). pedigreejs: a web-based graphical pedigree editor Bioinformatics,
  • Chen, WC., Kerr, R., May, A., Ndlovu, B., Sobalisa, A., Duze, ST., Joseph, L., Mathew, CG. and Babb de Villiers, CL., 2017 (Accepted for publication). The Integrity and Yield of Genomic DNA Isolated from Whole Blood Following Long-Term Storage at −30°C Biopreservation and Biobanking,
  • 2016

  • Schonfeld, SJ., Erdmann, F., Wiggill, T., Singh, E., Kellett, P., Babb, C. and Schüz, J., 2016. Hematologic malignancies in South Africa 2000-2006: analysis of data reported to the National Cancer Registry. Cancer Med, v. 5
    Doi: http://doi.org/10.1002/cam4.597
  • Halec, G., Schmitt, M., Egger, S., Abnet, CC., Babb, C., Dawsey, SM., Flechtenmacher, C., Gheit, T., Hale, M., Holzinger, D., Malekzadeh, R., Taylor, PR., Tommasino, M., Urban, MI., Waterboer, T., Pawlita, M., Sitas, F. and InterSCOPE Collaboration, , 2016. Mucosal alpha-papillomaviruses are not associated with esophageal squamous cell carcinomas: Lack of mechanistic evidence from South Africa, China and Iran and from a world-wide meta-analysis. Int J Cancer, v. 139
    Doi: http://doi.org/10.1002/ijc.29911
  • 2015

  • Singh, E., Ruff, P., Babb, C., Sengayi, M., Beery, M., Khoali, L., Kellett, P. and Underwood, JM., 2015. Establishment of a cancer surveillance programme: the South African experience. Lancet Oncol, v. 16
    Doi: http://doi.org/10.1016/S1470-2045(15)00162-X
  • Singh, E., Underwood, JM., Nattey, C., Babb, C., Sengayi, M. and Kellett, P., 2015. South African National Cancer Registry: Effect of withheld data from private health systems on cancer incidence estimates. S Afr Med J, v. 105
    Doi: http://doi.org/10.7196/samj.8858
  • Sengayi, M., Babb, C., Egger, M. and Urban, MI., 2015. HIV testing and burden of HIV infection in black cancer patients in Johannesburg, South Africa: a cross-sectional study. BMC Cancer, v. 15
    Doi: http://doi.org/10.1186/s12885-015-1171-7
  • Collaborative Group On Epidemiological Studies Of Ovarian Cancer, , Beral, V., Gaitskell, K., Hermon, C., Moser, K., Reeves, G. and Peto, R., 2015. Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet, v. 385
    Doi: http://doi.org/10.1016/S0140-6736(14)61687-1
  • 2014

  • Singh, E., Sengayi, M., Urban, M., Babb, C., Kellett, P. and Ruff, P., 2014. The South African National Cancer Registry: an update. Lancet Oncol, v. 15
    Doi: http://doi.org/10.1016/S1470-2045(14)70310-9
  • Babb, C., Urban, M., Kielkowski, D. and Kellett, P., 2014. Erratum to "prostate cancer in South Africa: pathology based national cancer registry data (1986-2006) and mortality rates (1997-2009)". Prostate Cancer, v. 2014
    Doi: http://doi.org/10.1155/2014/391257
  • Mendy, M., Caboux, E., Sylla, BS., Dillner, J., Chinquee, J., Wild, C. and BCNet survey participants, , 2014. Infrastructure and facilities for human biobanking in low- and middle-income countries: a situation analysis. Pathobiology, v. 81
    Doi: http://doi.org/10.1159/000362093
  • Babb, C., Urban, M., Kielkowski, D. and Kellett, P., 2014. Prostate cancer in South Africa: pathology based national cancer registry data (1986-2006) and mortality rates (1997-2009). Prostate Cancer, v. 2014
    Doi: http://doi.org/10.1155/2014/419801
  • 2013

  • Baker, G., Babb, C., Schnugh, D., Nayler, S., Louw, M., Goedhals, J., Bringuier, P-P., Blay, J-Y. and Willem, P., 2013. Molecular characterisation of gastrointestinal stromal tumours in a South African population. Oncol Lett, v. 5
    Doi: http://doi.org/10.3892/ol.2012.1013
  • 2012

  • Kielkowski, D., Singh, E., Wilson, K., Babb, C., Urban, M. and Kellett, P., 2012. The South African paediatric tumour registry - 25 years of activity. S Afr Med J, v. 102
    Doi: http://doi.org/10.7196/samj.6113
  • 2011

  • Boy, SC., van Heerden, MB., Babb, C., van Heerden, WF. and Willem, P., 2011. Dominant genetic aberrations and coexistent EBV infection in HIV-related oral plasmablastic lymphomas. Oral Oncol, v. 47
    Doi: http://doi.org/10.1016/j.oraloncology.2011.06.506
  • 2008

  • Djoba Siawaya, JF., Roberts, T., Babb, C., Black, G., Golakai, HJ., Stanley, K., Bapela, NB., Hoal, E., Parida, S., van Helden, P. and Walzl, G., 2008. An evaluation of commercial fluorescent bead-based luminex cytokine assays. PLoS One, v. 3
    Doi: http://doi.org/10.1371/journal.pone.0002535
  • 2007

  • Babb, C., van der Merwe, L., Beyers, N., Pheiffer, C., Walzl, G., Duncan, K., van Helden, P. and Hoal, EG., 2007. Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary tuberculosis patients. Tuberculosis (Edinb), v. 87
    Doi: http://doi.org/10.1016/j.tube.2007.03.001
  • Babb, C., Keet, EH., van Helden, PD. and Hoal, EG., 2007. SP110 polymorphisms are not associated with pulmonary tuberculosis in a South African population. Hum Genet, v. 121
    Doi: http://doi.org/10.1007/s00439-007-0335-1
  • Barreiro, LB., Neyrolles, O., Babb, CL., van Helden, PD., Gicquel, B., Hoal, EG. and Quintana-Murci, L., 2007. Length variation of DC-SIGN and L-SIGN neck-region has no impact on tuberculosis susceptibility. Hum Immunol, v. 68
    Doi: http://doi.org/10.1016/j.humimm.2006.10.020
  • 2006

  • Barreiro, LB., Neyrolles, O., Babb, CL., Tailleux, L., Quach, H., McElreavey, K., Helden, PDV., Hoal, EG., Gicquel, B. and Quintana-Murci, L., 2006. Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis. PLoS Med, v. 3
    Doi: http://doi.org/10.1371/journal.pmed.0030020
  • van Helden, PD., Möller, M., Babb, C., Warren, R., Walzl, G., Uys, P. and Hoal, E., 2006. TB epidemiology and human genetics. Novartis Found Symp, v. 279
  • Lombard, Z., Brune, AE., Hoal, EG., Babb, C., Van Helden, PD., Epplen, JT. and Bornman, L., 2006. HLA class II disease associations in southern Africa. Tissue Antigens, v. 67
    Doi: http://doi.org/10.1111/j.1399-0039.2006.00530.x